Resveratrol effect on ART outcome

Phase 3

Recruiting

• Conditions: polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20220815055705N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

patients must be infertile due to PCOS and aged between 18 and 40.
PCOS is diagnosed based on Rotterdam criteria and having 2 of 3 criteria is enough for diagnosis: amenorrhea or oligomenorrhea, clinical or biochemical hyperandrogenism manifestations, observation of cysts in ovary sonography (at least 12 follicles with diameter of 2 - 9 mm or an increase in ovary volume more than 10cm in tans-vaginal ultrasound radiography).

Exclusion Criteria

pregnancy
adrenal hyperplasia
androgen secreting tumors
hyperprolactinemia
thyroid malfunction
diabetes/glucose intolerance
male infertility factors
BMI > 30
taking anti-oxidant supplements less than 6 months prior to entering the study.
taking ovulation stimulating drugs less than 6 months prior to entering the study.
taking drugs with effect on hormone profile less than 6 months prior to entering the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified